Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1644-1652

  Hu, Siyu ^a   Li, Guoli ^b   Li, Hui ^c   Liu, Xiaoli ^d   Niu, Jianjun ^e   Quan, Shengmao ^a   Wang, Feng ^d   Wen, Huixin ^e   Xu, Ye ^a   Li, Qingge ^a  

^a XIAMEN UNIVERSITY   (China)

^b 309TH HOSPITAL OF PLA   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d Department of Pathological Laboratory Shenzhen Center for Chronic Disease Control ^*  (China)

^e Xiamen Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; BACTERIAL DNA; BACTERIAL PROTEIN;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL DISEASE IMMUNOFLUORESCENCE ASSAY; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC TEST ACCURACY STUDY; DNA SEQUENCE; DRUG SENSITIVITY; GENE MUTATION; LIMIT OF DETECTION; MELTING POINT; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BACTERIAL GENE; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; PROCEDURES; REPRODUCIBILITY; TUBERCULOSIS;

BACTERIAL PROTEINS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS;

EID: 84899569252     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03395-13     Document Type: Article

References (42)

1. World Health Organization. 2013. Global tuberculosis report 2013. World Health Organization, Geneva, Switzerland.
2. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, Pang Y, Song Y, Zhao B, Zhang H, He G, Guo J, Wang Y. 2012. National survey of drug-resistant tuberculosis in China. N. Engl. J. Med. 366:2161-2170. http://dx.doi.org/10.1056/NEJMoa1108789.
3. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. 2006. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosiswith low- and high-level resistance. J. Clin. Microbiol. 44:3659-3664. http://dx.doi.org/10. 1128/JCM.01054-06.
4. Anek-Vorapong R, Sinthuwattanawibool C, Podewils LJ, McCarthy K, Ngamlert K, Promsarin B, Varma JK. 2010. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand. BMC Infect. Dis. 10:123. http://dx.doi.org/10.1186/1471-2334-10-123.
5. Hillemann D, Rüsch-Gerdes S, Richter E. 2007. Evaluation of the Geno-Type MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640. http://dx.doi.org/10.1128/JCM.00521-07.
6. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. 2006. Use of Genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J. Clin. Microbiol. 44:2485-2491. http://dx.doi.org/10.1128/JCM.00083-06.
7. Crudu V, Stratan E, Romancenco E, Allerheiligen V, Hillemann A, Moraru N. 2012. First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances. J. Clin. Microbiol. 50:1264-1269. http://dx.doi.org/10.1128/JCM.05903-11.
8. Pang Y, Xia H, Zhang Z, Li J, Dong Y, Li Q, Ou X, Song Y, Wang Y, O'Brien R, Kam KM, Chi J, Huan S, Chin DP, Zhao Y. 2013. Multicenter evaluation of Genechip for detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 51:1707-1713. http://dx.doi.org/10.1128/JCM.03436-12.
9. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015. http://dx.doi.org/10.1056/NEJMoa0907847.
10. World Health Organization. 2011. Policy statement: automated realtime nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. World Health Organization, Geneva, Switzerland.
11. Huang Q, Liu Z, Liao Y, Chen X, Zhang Y, Li Q. 2011. Multiplex fluorescence melting curve analysis for mutation detection with duallabeled, self-quenched probes. PLoS One 6:e19206. http://dx.doi.org/10.1371/journal.pone. 0019206.
12. Hu S, Niu J, Quan S, Huang J, Li Q. 2011. Application and evaluation of a probe melting analysis-based assay for detection of isoniazid-resistant mutations in Mycobacterium tuberculosis. Chin. J. Lab. Med. 34:935-939. (In Chinese.) http://dx.doi.org/10.3760/cma.j.issn. 1009-9158.2011.10.015.
13. Li G, Li Q, Wang Q, Chen P, Zhang L. 2011. Evaluation of clinical application of PCR-probe melting analysis assay for detection of fluoroquinolone-resistant mutations in Mycobacterium tuberculosis clinical isolates. Chin. J. Clinicians 5:4641-4645. (In Chinese.) http://dx.doi.org/10. 3877/cma.j.issn. 1674-0785.2011.16.005.
14. Niu J, Zhang Y, Wen H, Liu X, Hu S, Li Q. 2011. Analyzing the mutations of rpoB gene in Mycobcterium tuberculosis clinical isolates by probe melting analysis assay. Chin. J. Prev. Med. 45:225-229. (In Chinese.) http://dx.doi.org/10.3760/cma.j.issn. 0253-9624.2011.03.007.
15. Zhang X, Zhang T, Niu J, Wen H, Hu S, Li Q. 2011. Probe melting analysis for rapid detection of strepomycin-resistant mutations in Mycobacterium tuberculosis clinical isolates. Chin. J. Zoonoses 27:53-57. (In Chinese.) http://www.cnki.com.cn/Article/CJFDTotal-ZRSZ201101015.htm.
16. Zheng R, Chen X, Fu J, Zhang X, Wen H, Hu S, Niu J, Li Q. 2011. Probe melting analysis for rapid detection of ethambutol-resistant mutations in Mycobacterium tuberculosis clinical isolates. Chin. J. Lab. Med. 34:130-134. (In Chinese.)
17. Chinese Antituberculosis Association. 2006. The laboratory science procedure of diagnostic bacteriology in tuberculosis, p 46-51. China Education and Culture Press, Beijing, China.
18. Center for Medical Device Evaluation. 1 June 2009, posting date. Guideline for evaluation of analytical performance of in vitro diagnostic kits. Center for Medical Device Evaluation, China Food and Drug Administration, Beijing, China.
19. Dean AG, Sullivan KM, Soe MM. 23 June 2011, posting date. OpenEpi: open source epidemiologic statistics for public health version 2.3.1. http://www. OpenEpi.com.
20. Boonaiam S, Chaiprasert A, Prammananan T, Leechawengwongs M. 2010. Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand. Clin. Microbiol. Infect. 16:396-399. http://dx.doi.org/10.1111/j.1469-0691.2009.02838.x.
21. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC. 2003. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 47:3799-3805. http://dx.doi.org/10. 1128/AAC.47.12.3799-3805.2003.
22. Gillespie SH. 2002. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob. Agents Chemother. 46:267-274. http://dx.doi.org/10.1128/AAC.46.2.267-274.2002.
23. World Health Organization. 2011. Guidelines for the programmatic management of drug-resistant tuberculosis-2011 update. World Health Organization, Geneva, Switzerland.
24. Jacobson KR, Theron D, Victor TC, Streicher EM, Warren RM, Murray MB. 2011. Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa. Clin. Infect. Dis. 53:369-372. http://dx.doi.org/ 10.1093/cid/cir406.
25. Bang D, Andersen PH, Andersen AB, Thomsen VØ. 2010. Isoniazidresistant tuberculosis in Denmark: mutations, transmission and treatment outcome. J. Infect. 60:452-457. http://dx.doi.org/10.1016/jjinf.2010. 03.017.
26. Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, Osmond D, Hopewell PC, Nahid P. 2009. Clinical characteristics and treatment outcomes of patients with isoniazidmonoresistant tuberculosis. Clin. Infect. Dis. 48:179-185. http://dx.doi.org/10.1086/595689.
27. Xiong F, Huang Q, Chen X, Zhou Y, Zhang X, Cai R, Chen Y, Xie J, Feng S, Wei X, Xiao Q, Zhang T, Luo S, Yang X, Hao Y, Qu Y, Li Q, Xu X. 2011. A melting curve analysis-based PCR assay for one-step genotyping of β-thalassemia mutations a multicenter validation. J. Mol. Diagn. 13:427-435. http://dx.doi.org/10.1016/j.jmoldx.2011.03.005.
28. Liao Y, Wang X, Sha C, Xia Z, Huang Q, Li Q. 2013. Combination of fluorescence color and melting temperature as a two-dimensional label for homogeneous multiplex PCR detection. Nucleic Acids Res. 41:e76. http://dx.doi.org/10.1093/nar/gkt004.
29. Liao Y, Zhou Y, Guo Q, Xie X, Luo E, Li J, Li Q. 2013. Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis. J. Clin. Microbiol. 51:429-435. http://dx.doi.org/10.1128/JCM.02115-12.
30. Ling DI, Zwerling AA, Pai M. 2008. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32:1165-1174. http://dx.doi.org/10.1183/09031936.00061808.
31. Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca LS, Ho JL, Kritski AL, Rossetti ML. 2009. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol. 9:39. http://dx.doi.org/10.1186/1471-2180-9-39.
32. Rinder H, Mieskes KT, Loscher T. 2001. Heteroresistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 5:339-345. http://www ingentaconnect.com/content/iuatld/ijtld/2001/00000005/00000004/art0 0008.
33. Hofmann-Thiel S, van Ingen J, Feldmann K, Turaev L, Uzakova GT, Murmusaeva G, van Soolingen D, Hoffmann H. 2009. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur. Respir. J. 33:368-374. http://dx.doi.org/10.1183/09031936.00089808.
34. Ådjers-Koskela K, Katila ML. 2003. Susceptibility testing with the manual Mycobacteria Growth Indicator Tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis. J. Clin. Microbiol. 41:1235-1239. http://dx.doi.org/10.1128/JCM.41.3.1235-1239. 2003.
35. Karahan ZC, Akar N. 2005. Restriction endonuclease analysis as a solution for determining rifampin resistance mutations by automated DNA sequencing in heteroresistant Mycobacterium tuberculosis strains. Microb. Drug Resist. 11:137-140. http://dx.doi.org/10.1089/mdr.2005.11.137.
36. de Oliveira MM, da Silva Rocha A, Cardoso Oelemann M, Gomes HM, Fonseca L, Werneck-Barreto AM, Valim AM, Rossetti ML, Rossau R, Mijs W, Vanderborght B, Suffys P. 2003. Rapid detection of resistance against rifampicin in isolates of Mycobacterium tuberculosis from Brazilian patients using a reverse-phase hybridization assay. J. Microbiol. Methods 53:335-342. http://dx.doi.org/10. 1016/S0167-7012 (02) 00253-1.
37. Engström A, Hoffner S, Juréen P. 2013. Detection of heteroresistant Mycobacterium tuberculosis by pyrosequencing. J. Clin. Microbiol. 51:4210-4212. http://dx.doi.org/10.1128/JCM.01761-13.
38. Chakravorty S, Aladegbami B, Thoms K, Lee JS, Lee EG, Rajan V, Cho EJ, Kim H, Kwak H, Kurepina N, Cho SN, Kreiswirth B, Via LE, Barry CE III, Alland D. 2011. Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay. J. Clin. Microbiol. 49:932-940. http://dx.doi.org/10.1128/JCM.02271-10.
39. Chakravorty S, Kothari H, Aladegbami B, Cho EJ, Lee JS, Roh SS, Kim H, Kwak H, Lee EG, Hwang SH, Banada PP, Safi H, Via LE, Cho SN, Barry CE, III, Alland D. 2012. Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding. J. Clin. Microbiol. 50:2194-2202. http://dx.doi.org/10.1128/JCM.00143-12.
40. Folkvardsen DB, Svensson E, Thomsen VØ, Rasmussen EM, Bang D, Werngren J, Hoffner S, Hillemann D, Rigouts L. 2013. Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis? J. Clin. Microbiol. 51:1596-1599. http://dx.doi.org/10.1128/JCM.00472-13.
41. Folkvardsen DB, Thomsen VØ, Rigouts L, Rasmussen EM, Bang D, Bernaerts G, Werngren J, Toro JC, Hoffner S, Hillemann D, Svensson E. 2013. Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methods. J. Clin. Microbiol. 51:4220-4222. http://dx.doi.org/10.1128/JCM.01602-13.
42. Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, León CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de León A, Alland D. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50:2640-2649. http://dx.doi.org/10.1128/AAC.00112-06.